Mussel Intake and Vitamin D Status in Humans
Mussel
Effect of Mussel Intake on Vitamin D Status Study
1 other identifier
interventional
20
1 country
1
Brief Summary
A significant proportion of the United Kingdom population have inadequate levels of vitamin D in their blood. Vitamin D is a fat-soluble vitamin that is essential for the growth and maintenance of healthy bones through increasing dietary calcium absorption within the body. A low vitamin D status has also been associated with other diseases such as osteoporosis, cancer (especially colorectal cancer), cardiovascular disease and type 1 diabetes. Our skin is able to synthesise vitamin D upon exposure to sunlight in summer. If exposure to sunlight is limited, then a dietary supply of vitamin D becomes essential. However, very few foods contain vitamin D. Among the best dietary sources of vitamin D are oily fish (including salmon, mackerel, herring and trout) and fish oils. Recently, the investigators found that certain shellfish, especially mussels, contain significant amounts of a metabolite of vitamin D, 25(OH)D3. Consumption of this metabolite, as a supplement, has already been shown to improve vitamin D status in humans. Whether consumption of mussels improves vitamin D status is unknown. In this study the investigators will be looking at whether consumption of 1, 2 or 3 portions of mussels per week for 12 weeks increases vitamin D status in healthy people.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 28, 2016
CompletedFirst Submitted
Initial submission to the registry
December 1, 2016
CompletedFirst Posted
Study publicly available on registry
December 5, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedOctober 9, 2019
October 1, 2019
5 months
December 1, 2016
October 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Vitamin D status
Serum Vitamin D status will be assessed by measuring plasma 25-hydroxy vitamin D3 by Liquid Chromatography/Mass Spectrometry, the gold standard method
At baseline and after 12 weeks mussel supplementation
Secondary Outcomes (2)
Vitamin B12 status
At baseline and after 12 weeks mussel supplementation
Change in omega-3 index
At baseline and after 12 weeks mussel supplementation
Study Arms (4)
No Mussels
EXPERIMENTALThe control group will continue to consume their normal habitual diet
One mussel portion
EXPERIMENTALOne 75g portion of Scottish mussels provided per week for 12 weeks on top of normal habitual shellfish consumption.
Two mussel portions
EXPERIMENTALTwo 75g portions of Scottish mussels provided per week for 12 weeks on top of normal habitual shellfish consumption
Three mussel portions
EXPERIMENTALThree 75g portion of Scottish mussels provided per week for 12 weeks on top of normal habitual shellfish consumption
Interventions
3 x 75g mussel portions provided per week
Eligibility Criteria
You may qualify if:
- BMI ranging from 18-35
- Not having any food allergies
- Not taking any fish oil or certain nutritional / vitamin supplements
- Non-smoker
You may not qualify if:
- Regularly take aspirin or aspirin-containing drugs
- Taking drugs or herbal medicines known to alter the haemostatic system in general
- Taking certain dietary supplements / multivitamin tablets
- Anyone suffering from diabetes, hypertension, renal, hepatic or haematological disease
- Heart / circulation problems
- Eating disorders
- Smoking
- Any existing shellfish allergy
- Having difficult venous access or problems giving blood in the past
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Aberdeen, The Rowett Institute
Aberdeen, AB25 2ZD, United Kingdom
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Baukje De Roos, PhD
University of Aberdeen, The Rowett Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2016
First Posted
December 5, 2016
Study Start
November 28, 2016
Primary Completion
April 20, 2017
Study Completion
December 31, 2018
Last Updated
October 9, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share